101 related articles for article (PubMed ID: 22503234)
1. Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience.
Shah C; Berry S; Dekhne N; Lanni T; Lowry H; Vicini F
Clin Breast Cancer; 2012 Jun; 12(3):215-8. PubMed ID: 22503234
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ
Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108
[TBL] [Abstract][Full Text] [Related]
4. MRI screening in a clinic population with a family history of breast cancer.
Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
[TBL] [Abstract][Full Text] [Related]
5. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk assessment in indigent women at a public hospital.
Abu-Rustum NR; Herbolsheimer H
Gynecol Oncol; 2001 May; 81(2):287-90. PubMed ID: 11330964
[TBL] [Abstract][Full Text] [Related]
8. [Risk of invasive breast cancer in Mexican population and patterns of screening and prophylaxis].
Medina-Franco H; Garza E; Gabilondo B; Gaona-Luviano P
Rev Invest Clin; 2004; 56(4):422-6. PubMed ID: 15587286
[TBL] [Abstract][Full Text] [Related]
9. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
10. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
11. Breast MRI surveillance in women with prior curative-intent therapy for breast cancer.
Elmore L; Margenthaler JA
J Surg Res; 2010 Sep; 163(1):58-62. PubMed ID: 20605594
[TBL] [Abstract][Full Text] [Related]
12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
13. Screening and follow-up of the patient at high risk for breast cancer.
Willey SC; Cocilovo C
Obstet Gynecol; 2007 Dec; 110(6):1404-16. PubMed ID: 18055740
[TBL] [Abstract][Full Text] [Related]
14. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
[TBL] [Abstract][Full Text] [Related]
15. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
16. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
17. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey.
Sabatino SA; Burns RB; Davis RB; Phillips RS; Chen YH; McCarthy EP
Cancer; 2004 Jun; 100(11):2338-46. PubMed ID: 15160336
[TBL] [Abstract][Full Text] [Related]
19. Population-based screening for hereditary breast cancer in a region of North-Central Italy.
Casadei S; Falcini F; Naldoni C; Amadori D; Calistri D
Int J Mol Med; 2002 Sep; 10(3):299-305. PubMed ID: 12165804
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Loehberg CR; Jud SM; Haeberle L; Heusinger K; Dilbat G; Hein A; Rauh C; Dall P; Rix N; Heinrich S; Buchholz S; Lex B; Reichler B; Adamietz B; Schulz-Wendtland R; Beckmann MW; Fasching PA
Breast Cancer Res Treat; 2010 May; 121(1):101-10. PubMed ID: 20306293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
